REG - Metir PLC - Fundraise

MetirAnnouncement

22/12/2025 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251222:nRSV3674Ma&default-theme=true

RNS Number : 3674M  Metir PLC  22 December 2025

 

 

THIS ANNOUNCEMENT IS NOT FOR PUBLICATION, RELEASE OR DISTRIBUTION, DIRECTLY OR
INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO OR FROM THE UNITED STATES OR ANY
OTHER JURISDICTION IN WHICH SUCH PUBLICATION, RELEASE OR DISTRIBUTION WOULD BE
UNLAWFUL. THIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND DOES NOT
CONSTITUTE AN OFFER OR AN INVITATION TO ACQUIRE OR DISPOSE OF ANY SECURITIES.
ATTENTION IS ALSO DRAWN TO THE IMPORTANT INFORMATION AT THE END OF THIS
ANNOUNCEMENT.

 
22 December 2025

 

Metir plc

 

("Metir", the "Group" or the "Company")

 

Fundraise

 

Metir plc (AIM: MET), the leading global provider of fast response mobile and
point-of-use water and environmental testing technology, is pleased to
announce the successful completion of a fundraise (the "Fundraise"), arranged
by the Company's Joint Broker Turner Pope Investments Limited ("TPI"), to
raise up to £1,000,000, before expenses, to support the continuing growth of
the Company by way of a placing of 133,333,333 new Ordinary Shares of 0.001
pence each in the Company ("Ordinary Shares") with investors ("Placing
Shares"; together the "Placing") at a price of 0.75p (the "Placing Price") per
ordinary share. In connection with the Placing, the Company will issue
133,333,333 warrants to investors on the basis of one (1) warrant for every
one (1) Placing Share. Each warrant entitles the holder to subscribe for one
additional Ordinary Share at an exercise price of 1.5p (representing a 100%
premium to the Placing Price), exercisable for a period of 24 months from the
date of issuance (the "Investor Warrants").

 

Use of proceeds

As announced in the trading update on 2 December 2025, the cost base of the
Company remains very tightly controlled and is supporting strong growth but
management believes that this growth is being constrained by sub-optimal
levels of working capital. The Board believes that additional financing would
support stronger growth and move the Company into profitability more quickly.

 

The net proceeds of the Fundraise are intended to provide capital to
accelerate growth of the business and move towards profitability including for
the following purposes:

 

·    Increasing production capacity of Microtox® LX and FX
instruments and Sulphate Reducing Bacteria (SRB) kits to meet growing
customer demand, reduce delivery times and support improved manufacturing
efficiency and margins.

·    Providing additional working capital to support inventory build,
manufacturing scale-up and the conversion of the Company's growing order book
into revenue.

·    Supporting large-scale, continuous potable water monitoring projects,
including the operational scaling of 24/7 Continuous Toxic Monitoring (CTM)
installations and expansion of opportunities, building on the successful Qatar
deployment.

·    Further development and optimisation of CTM software and system
performance, enhancing automation, reliability and scalability for utility and
state-operated customers.

·    Ongoing investment in product development, including optimisation of
the Company's market-leading PFAS technologies and progression of
next-generation detection capabilities.

·    Investing in management infrastructure, including sales and marketing
team and distribution network.

 

Placing

Pursuant to the Placing, a total of 133,333,333 Ordinary Shares ("Placing
Shares") have been placed, conditional only on admission to trading on AIM
("Admission"), with investors at the Placing Price, representing a discount of
3.23% to the closing mid‐market price prior to the Placing of 0.775p on 19
December 2025 (being the last practicable date prior to this announcement).
Each Placing Share will rank pari passu with existing Ordinary Shares.

 

In connection with the Placing, the Company will issue 133,333,333 warrants to
investors on the basis of one (1) warrant for every one (1) Placing Share.
Each warrant entitles the holder to subscribe for one additional Ordinary
Share at an exercise price of 1.5p (representing a 100% premium to the Placing
Price), exercisable for a period of 2 years from the date of Admission (the
"Investor Warrants").

 

The Placing Shares represent approximately 30% of the enlarged issued share
capital of the Company and together with the Broker Warrants (as described
below) would represent approximately 46% of the diluted issued share capital
(assuming no other warrants or options are exercised).

 

Turner Pope Investments (TPI) Limited ("Turner Pope" or "TPI") is acting as
broker and placing agent to the Company and Singer Capital Markets Advisory
LLP ("Singer Capital Markets") is acting as Nominated Adviser to the Company.
Under the terms of engagement between TPI and the Company, the Company has
agreed to issue TPI warrants to subscribe for 13,333,333 Ordinary Shares in
connection with the Placing exercisable at the Placing Price for 5 years from
the date of Admission (the "Broker Warrants"). The issue of the Broker
Warrants is conditional upon Admission.

 

Related party transaction

 

Dr. Nigel Burton is investing £50,000 in the Placing, equating to 6,666,667
Placing Shares, and will hold an aggregate 16,809,502 Ordinary Shares from
Admission. Dr. Nigel Burton is a director of the Company and as such is
considered a related party of the Company for the purposes of the AIM Rules
for Companies. The participation of Dr. Nigel Burton in the Placing
constitutes a related party transaction pursuant to Rule 13 of the AIM Rules
for Companies. The Company's independent directors (being Bob Moore, Executive
Chairman and Chief Executive Officer, and Dr. Chris Potts, Non-Executive
Director), having consulted with the Company's nominated adviser, Singer
Capital Markets Advisory LLP, consider that the terms of the participation of
Dr. Nigel Burton in the Placing, on the same terms as other investors, are
fair and reasonable insofar as the Company's shareholders are concerned.

 

Admission to trading

An application will be made to the London Stock Exchange plc for admission of
the Placing Shares totalling 133,333,333 Ordinary Shares to trading on AIM. It
is expected that admission will become effective and dealings in the Placing
Shares will commence at 8.00 a.m. on or around 24 December 2025.

 

Total Voting Rights

Following the issue of the Placing Shares as described above, the Company's
issued ordinary share capital will consist of 443,239,487 Ordinary Shares. The
Company does not hold any Ordinary Shares in Treasury.

 

Therefore, the above figure may be used by shareholders in the Company as the
denominator for the calculation by which they will determine if they are
required to notify their interest in, or a change to their interest in, the
share capital of the Company under the FCA's Disclosure Guidance and
Transparency Rules.

 

Cash

Following completion of the Placing and after its associated expenses, the
Company's net cash position is expected to be approximately £1,088,000 and
the Company will have adequate working capital headroom to continue to operate
for the foreseeable future.

 

Bob Moore, Executive Chairman and Chief Executive Officer of Metir plc,
commented:

 

"As highlighted in the Company's recent trading update, customer demand across
our instruments, reagents and testing kits continues to grow, supported by a
strong international pipeline. While commercial momentum is encouraging, the
pace at which we can convert this demand into revenue is currently constrained
by working capital and manufacturing capacity.

 

"This Fundraise will enable us to accelerate instrument production, support
larger-scale continuous toxic monitoring projects building on our success in
Qatar, and advance several high-value technologies towards commercialisation.
Together, these initiatives will strengthen our recurring revenue model and
support our objective of moving the business towards sustainable
profitability. We look forward to providing regular updates on the Company's
progress.

 

"We are grateful for the continued support of existing shareholders and the
confidence shown by new investors."

 

The information contained within this announcement is deemed by the Company to
constitute inside information for the purposes of Article 7 of the Market
Abuse Regulation (EU) No. 596/2014 as it forms part of UK domestic law by
virtue of the European Union (Withdrawal) Act 2018. Upon the publication of
this announcement via the Regulatory Information Service, this inside
information is now considered to be in the public domain.

 

This announcement contains (or may contain) certain forward-looking statements
with respect to certain of the Company's and/or the Directors' current
expectations and projections about future events. These statements, which
sometimes use words such as "anticipate", "believe", "intend", "estimate",
"expect" and words of similar meaning, reflect the directors' beliefs and
expectations and involve a number of risks, uncertainties and assumptions that
could cause actual results and performance to differ materially from any
expected future results or performance expressed or implied by any such
forward-looking statement. Statements contained in this announcement regarding
past trends or activities should not be taken as a representation that such
trends or activities will continue in the future. The information contained in
this announcement is subject to change without notice and neither Singer
Capital Markets nor TPI nor, except as required by applicable law, the Company
assumes any responsibility or obligation to update publicly or review any of
the forward-looking statements contained herein. You should not rely on
forward-looking statements, which speak only as of the date of this
announcement.

 

-      Ends -

 

Enquiries:

 

 Metir plc                                                   +44 (0) 20 3657 0050

 Bob Moore, Executive Chairman and Chief Executive Officer   via TPI

 Singer Capital Markets                                      +44 (0)20 7496 3000

(Nominated Adviser & Joint Broker)

 Alex Bond / James Fischer / Anastassiya Eley

 Turner Pope Investments (TPI) Limited                       +44 (0) 20 3657 0050

(Joint Broker)

 Andrew Thacker / Guy McDougall

 

 Northstar Communications (Investor Relations)  +44 (0) 113 730 3896

 Sarah Hollins

 

About Metir

 

Metir plc is a leading global provider of fast response, mobile and
point-of-use water and environmental testing technology. Through its two
established trading divisions, Modern Water and Microsaic Systems a specialist
in mobile PFAS monitoring, the Company develops and supplies innovative,
easy-to-use solutions that deliver rapid, accurate water and liquids quality
results, helping industries, utilities and regulators monitor safety and
compliance in real time.

 

With a strong focus on data-driven insight and field-ready design, Metir's
technology supports critical decision-making across sectors, including
environmental monitoring, public health and industrial process management.

 

Headquartered in York, UK, Metir serves worldwide customers and is dedicated
to advancing water testing standards through innovative, accessible solutions.

 

For more information, please visit: https://www.metirplc.com
(https://www.metirplc.com)

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  ROIGPGRPPUPAGRB



            Copyright 2019 Regulatory News Service, all rights reserved